Sniffing away sickness: aromatherapy tested for chemo nausea
NCT ID NCT07209501
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether aromatherapy inhaler sticks can reduce nausea and vomiting in 30 patients receiving chemotherapy as part of a stem cell transplant. Participants use the inhaler every four hours and whenever they feel sick. Half get essential oils, half get a placebo (jojoba oil only). The study mainly checks if this approach is practical and acceptable, and also tracks nausea severity and vomiting episodes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- aromatherapy inhaler with essential oils
- What this could lead to
- If it works, this could offer a simple, drug-free way to ease nausea and vomiting during chemotherapy for stem cell transplant patients.
- What could go wrong
- This is a very small pilot study (30 people) focused on feasibility, not proof of effectiveness. The results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Singapore General Hospital
Singapore, 169608, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact